Peptide Research Glossary

Amino acids are organic molecules that serve as the building blocks of peptides and proteins. Each amino acid contains an amino group (-NH2), a carboxyl group (-COOH), and a unique side chain (R group) that determines its chemical properties. There are 20 standard amino acids encoded by DNA. Peptides are formed when amino acids link together through peptide bonds in a specific sequence. The sequence and number of amino acids determine the peptide's structure, function, and biological activity.

AMP-activated protein kinase (AMPK) is a highly conserved serine/threonine kinase that functions as a master regulator of cellular energy homeostasis. AMPK is activated when the AMP-to-ATP ratio increases, signaling low energy status, and responds by stimulating catabolic pathways such as fatty acid oxidation, glucose uptake, and autophagy while inhibiting anabolic processes like protein and lipid synthesis. The mitochondria-derived peptide MOTS-c has been shown to activate AMPK signaling, and AMPK is a key node connecting metabolic sensing to exercise mimetic effects and longevity pathways.

Anabolic refers to metabolic processes that build complex molecules from simpler ones, requiring energy input. In the context of peptide research, anabolic processes include muscle protein synthesis, collagen production, and bone formation. Growth hormone secretagogues, IGF-1 LR3, and follistatin promote anabolic pathways through different mechanisms — GH/IGF-1 axis stimulation and myostatin inhibition respectively.

Angiogenesis is the physiological process of forming new blood vessels from pre-existing vasculature. It is a critical component of wound healing, tissue repair, and regeneration, as new blood vessels deliver oxygen and nutrients to damaged or growing tissue. Both BPC-157 and TB-500 have demonstrated pro-angiogenic properties in preclinical research — BPC-157 through modulation of the NO system and VEGF expression, and TB-500 through promotion of endothelial cell migration and differentiation.

Antimicrobial peptides (AMPs) are a diverse class of naturally occurring peptides that form part of the innate immune defense against bacteria, viruses, and fungi. AMPs typically carry a net positive charge that enables electrostatic interaction with negatively charged microbial membranes, leading to membrane disruption and cell lysis. LL-37 is a well-characterized human AMP, and KPV exhibits anti-inflammatory properties related to the melanocortin system's antimicrobial functions.

An anxiolytic is any compound that reduces anxiety. Unlike traditional benzodiazepine anxiolytics that act on GABA receptors with sedation and dependence risks, peptide anxiolytics such as Selank operate through distinct mechanisms including modulation of enkephalin metabolism and BDNF expression. Selank has demonstrated anxiolytic effects comparable to benzodiazepines in preclinical models without the associated sedation or withdrawal effects.

Apoptosis is a genetically regulated form of programmed cell death characterized by cell shrinkage, chromatin condensation, membrane blebbing, and fragmentation into apoptotic bodies that are phagocytosed without triggering inflammation. Apoptosis is mediated through two main pathways: the intrinsic (mitochondrial) pathway, triggered by intracellular stress signals, and the extrinsic (death receptor) pathway, activated by extracellular ligands such as TNF and FasL. Dysregulated apoptosis is implicated in numerous pathologies, with excessive apoptosis contributing to neurodegenerative diseases and insufficient apoptosis enabling cancer progression. Several research peptides modulate apoptotic pathways, with some exhibiting cytoprotective effects.

Autophagy (from Greek, meaning 'self-eating') is a highly conserved intracellular degradation process in which cytoplasmic components, including damaged organelles and misfolded proteins, are sequestered within double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. Autophagy serves as a critical quality control mechanism that maintains cellular homeostasis, and its activation is regulated by nutrient-sensing pathways including mTOR and AMPK. Impaired autophagy is associated with aging, neurodegeneration, and metabolic disease, while enhanced autophagy is believed to mediate some of the benefits of caloric restriction and exercise on healthspan.

Bacteriostatic water is sterile water that contains 0.9% benzyl alcohol as a bacteriostatic preservative. It is the preferred solvent for reconstituting lyophilized peptides because the preservative inhibits bacterial growth, allowing the reconstituted solution to be used over multiple research sessions (typically up to 28 days when stored properly at 2-8°C). This differs from sterile water for injection, which contains no preservative and must be used in a single session to avoid contamination.

Bioavailability refers to the fraction of an administered substance that reaches systemic circulation in its active form. For peptides, bioavailability varies significantly depending on the route of administration. Oral bioavailability of most peptides is typically very low (under 2%) due to enzymatic degradation in the GI tract and poor membrane permeability. BPC-157 is notable among peptides for its demonstrated stability in gastric juice, which may contribute to higher oral bioavailability compared to other peptide compounds.

Bioconjugation is the chemical strategy of linking a peptide or biomolecule to another entity such as a fatty acid, polymer, antibody, or carrier protein to alter its pharmacological properties. In peptide research, bioconjugation techniques like lipidation (e.g., palmitoylation in semaglutide) and PEGylation are used to extend half-life, improve stability, and enhance tissue targeting.

A biomarker is a measurable biological indicator used to assess physiological states, disease processes, or pharmacological responses. In peptide research, common biomarkers include serum IGF-1 levels (for growth hormone secretagogue activity), HbA1c (for metabolic peptide efficacy), BDNF levels (for neuroprotective peptides), and telomere length (for anti-aging research). Biomarkers enable objective quantification of peptide effects in both preclinical and clinical studies.

The blood-brain barrier (BBB) is a highly selective semipermeable border of endothelial cells connected by tight junctions that separates the circulating blood from the brain extracellular fluid and central nervous system. The BBB restricts the passage of most molecules larger than approximately 400-500 Daltons, including the majority of peptides, while allowing the transport of essential nutrients, gases, and select small lipophilic molecules. Strategies to deliver peptides across the BBB include intranasal administration (exploiting the olfactory/trigeminal pathway), receptor-mediated transcytosis, and structural modifications to enhance lipophilicity or exploit endogenous transport systems.

Brain-Derived Neurotrophic Factor (BDNF) is a member of the neurotrophin family of growth factors that plays a critical role in neuronal survival, synaptic plasticity, learning, and memory. BDNF signals primarily through the TrkB receptor tyrosine kinase, activating downstream pathways including PI3K/Akt and MAPK/ERK that support neurogenesis and long-term potentiation. Reduced BDNF levels are associated with neurodegenerative diseases and depression. The synthetic peptides semax and dihexa have been investigated for their ability to upregulate BDNF expression and enhance neurotrophic signaling in preclinical models.

Cell culture is the process of growing and maintaining cells under controlled laboratory conditions outside their natural environment, typically in flasks or multiwell plates with nutrient media. Primary cell cultures are derived directly from tissue, while immortalized cell lines can be passaged indefinitely. Cell culture systems are the foundation of in vitro peptide research, enabling studies of receptor binding, signaling pathways, and cytotoxicity.

Cellular senescence is a state of irreversible cell cycle arrest in which cells remain metabolically active but cease dividing. Senescent cells accumulate with age and secrete pro-inflammatory cytokines, chemokines, and proteases collectively known as the senescence-associated secretory phenotype (SASP), contributing to chronic inflammation and tissue dysfunction. Senolytic peptides like FOXO4-DRI target senescent cells for elimination as a potential anti-aging strategy.

A Certificate of Analysis (COA) is a document issued by a quality control laboratory that confirms a product meets its specified quality standards. For research peptides, a COA typically includes HPLC purity data (chromatogram and percentage), mass spectrometry results confirming molecular identity, appearance description, lot/batch number, and storage recommendations. A reputable peptide supplier provides batch-specific COAs for every product, enabling researchers to verify the quality and identity of their materials.

Circadian rhythms are approximately 24-hour biological cycles driven by the suprachiasmatic nucleus and peripheral clocks that regulate sleep-wake patterns, hormone secretion, metabolism, and body temperature. Many peptide hormones including growth hormone, cortisol, and melatonin exhibit strong circadian secretion patterns. DSIP (delta sleep-inducing peptide) and Epithalon (which stimulates melatonin-producing pinealocytes) interact with circadian regulation.

A clinical trial is a structured research study conducted in human participants to evaluate the safety, efficacy, dosing, and side effects of a medical intervention. Clinical trials proceed through phases: Phase I (safety and dosing in small groups), Phase II (efficacy and side effects), Phase III (large-scale efficacy confirmation), and Phase IV (post-market surveillance). Peptides like semaglutide and tirzepatide have completed full clinical trial programs leading to regulatory approval.

Collagen is the most abundant structural protein in the human body, comprising approximately 30% of total protein content, and is the primary component of connective tissues including skin, tendons, ligaments, cartilage, and bone. The collagen superfamily includes at least 28 types, with types I, II, and III being the most prevalent. Collagen is characterized by its triple-helix structure formed by three polypeptide chains rich in glycine-proline-hydroxyproline repeats. Collagen synthesis declines with age and is impaired by oxidative stress, UV radiation, and inflammation. The tripeptide GHK-Cu has been shown to stimulate collagen synthesis and remodeling in dermatological and wound-healing research.

Cytokines are small signaling proteins secreted by immune cells that regulate inflammation, immunity, and hematopoiesis. Pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6) drive inflammatory responses, while anti-inflammatory cytokines (IL-10, TGF-beta) resolve them. Several research peptides modulate cytokine profiles — BPC-157 and KPV reduce pro-inflammatory cytokine production, thymosin alpha-1 balances Th1/Th2 cytokine responses, and VIP acts as an anti-inflammatory neuropeptide.

A dipeptide is a molecule consisting of two amino acids joined by a single peptide bond. Despite their small size, dipeptides can have significant biological activity — carnosine (beta-alanyl-L-histidine) is a naturally occurring dipeptide with antioxidant and anti-glycation properties. Dipeptides are generally more resistant to proteolysis than larger peptides and may be absorbed intact through intestinal peptide transporters (PepT1).

A disulfide bond is a covalent bond formed between the sulfur atoms of two cysteine residues in a peptide or protein. These bonds play a critical role in stabilizing three-dimensional structure and are essential for the biological activity of many peptides. In peptide synthesis and handling, maintaining correct disulfide bond formation is crucial — improper folding can result in inactive or misfolded products. Storage conditions (temperature, absence of reducing agents) help preserve disulfide bond integrity.

A dose-response curve is a graphical representation of the relationship between the amount of a substance administered and the magnitude of its biological effect. The curve typically follows a sigmoidal shape, with key parameters including the EC50 (half-maximal effective concentration), the maximum response (Emax), and the Hill coefficient describing cooperativity. Dose-response relationships are fundamental to establishing effective research concentrations for peptides.

EC50 is a pharmacological measure representing the concentration of an agonist that produces 50% of the maximal possible effect in a dose-response curve. It is a standard metric for quantifying the potency of receptor agonists and other activating compounds. A lower EC50 indicates higher potency, meaning a smaller concentration is required to achieve half-maximal activation. In peptide research, EC50 values are used to compare the relative potencies of peptide analogs at their target receptors and to guide concentration selection for in vitro and in vivo studies.

An endogenous peptide is a peptide that is naturally produced within the body as part of normal physiological processes. Examples include GLP-1 (incretin hormone), GnRH/gonadorelin (reproductive hormone), oxytocin (social bonding neuropeptide), and GHK-Cu (wound healing tripeptide). Many research peptides are synthetic analogs of endogenous peptides, modified to improve stability, selectivity, or duration of action.

Endotoxin testing is an analytical quality control procedure used to detect and quantify bacterial endotoxins (lipopolysaccharides, LPS) shed from the outer membrane of Gram-negative bacteria. The Limulus Amebocyte Lysate (LAL) assay is the gold standard method, utilizing a clotting cascade from horseshoe crab blood cells that is activated by endotoxin. Endotoxin contamination in research peptides can confound experimental results by activating innate immune responses and inducing pyrogenic reactions. Peptides intended for in vivo research typically require endotoxin levels below 5 EU/kg body weight.

Epigenetics refers to heritable changes in gene expression that occur without alterations to the DNA sequence itself, mediated by mechanisms including DNA methylation, histone modification, and non-coding RNA regulation. Age-related epigenetic changes are a hallmark of biological aging. Epithalon has been studied for its effects on telomerase activation which intersects with epigenetic regulation, and GHK-Cu has been shown to modulate the expression of thousands of genes, suggesting broad epigenetic influence.

The erythropoietin receptor (EPOR) is a cytokine receptor that, when activated by erythropoietin (EPO), promotes red blood cell production. A heterodimer of EPOR with the beta common receptor (betacR/CD131) forms the innate repair receptor (IRR), which mediates tissue-protective and anti-inflammatory effects distinct from erythropoiesis. ARA-290 (cibinetide) selectively activates the IRR without stimulating red blood cell production, providing neuroprotective and anti-inflammatory benefits.

Excitotoxicity is a pathological process in which neurons are damaged or killed by excessive stimulation from excitatory neurotransmitters, particularly glutamate. Overactivation of NMDA and AMPA receptors leads to massive calcium influx, mitochondrial dysfunction, and cell death. Several neuroprotective peptides including Semax, PE-22-28, and Cerebrolysin have demonstrated the ability to attenuate excitotoxic neuronal damage in preclinical models.

An exercise mimetic is a compound that replicates some of the molecular and physiological benefits of physical exercise without the actual physical activity. Exercise mimetics typically activate pathways such as AMPK, PGC-1alpha, and estrogen-related receptors (ERRs) that are normally induced by exercise. MOTS-c and SLU-PP-332 are notable peptide/small molecule exercise mimetics — MOTS-c activates AMPK to improve metabolic fitness, while SLU-PP-332 activates ERR signaling to enhance endurance capacity.

Ferroptosis is a form of regulated cell death driven by iron-dependent lipid peroxidation, distinct from apoptosis, necrosis, and autophagy. It is characterized by accumulation of lipid reactive oxygen species and depletion of glutathione peroxidase 4 (GPX4). Ferroptosis has been implicated in neurodegeneration, cardiac injury, and cancer. Thymosin beta-4 (TB-500) has been studied for its ability to inhibit ferroptosis in cardiac tissue models.

Fibroblasts are the most common cells in connective tissue, responsible for synthesizing the extracellular matrix including collagen, elastin, and glycosaminoglycans. They play a central role in wound healing, tissue repair, and fibrosis. Fibroblast cultures are widely used in peptide research — BPC-157 has been shown to enhance fibroblast migration and growth hormone receptor expression, while GHK-Cu stimulates fibroblast collagen production.

First-pass metabolism (also called the first-pass effect or presystemic metabolism) is the phenomenon by which an orally administered substance is extensively metabolized by the liver and gut wall before reaching systemic circulation, significantly reducing its bioavailability. Peptides are particularly susceptible to first-pass metabolism due to the abundance of proteolytic enzymes in the gastrointestinal tract and hepatic tissue. This is why most research peptides are administered via parenteral routes (subcutaneous, intravenous, or intranasal) to bypass first-pass degradation and achieve effective systemic concentrations.

G protein-coupled receptors (GPCRs) are the largest family of cell surface receptors, characterized by seven transmembrane domains and signal transduction through intracellular G proteins. Many peptide hormones and research peptides act through GPCRs — including GLP-1 receptor agonists (semaglutide, tirzepatide), melanocortin receptor agonists (PT-141, melanotan II), and growth hormone secretagogues (ipamorelin, GHRP-2, GHRP-6).

The growth hormone secretagogue receptor type 1a (GHS-R1a), also known as the ghrelin receptor, is a G protein-coupled receptor primarily expressed in the hypothalamus and pituitary gland. Activation of GHS-R1a by ghrelin or synthetic peptide agonists like GHRP-2, GHRP-6, and ipamorelin stimulates growth hormone release, increases appetite, and modulates energy metabolism. GHS-R1a is the primary therapeutic target for growth hormone secretagogue peptides.

Glucagon-Like Peptide-1 (GLP-1) is a 30-amino acid incretin hormone produced by intestinal L-cells in response to nutrient ingestion. GLP-1 enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and promotes satiety through central nervous system signaling. The native peptide has a very short half-life of approximately 2 minutes due to rapid degradation by dipeptidyl peptidase-4 (DPP-4). GLP-1 receptor agonists such as semaglutide and liraglutide have been engineered with structural modifications to resist enzymatic degradation and extend their duration of action.

Glucose-dependent Insulinotropic Polypeptide (GIP) is a 42-amino acid incretin hormone secreted by K-cells in the duodenum and jejunum in response to dietary carbohydrates and fats. GIP stimulates insulin secretion in a glucose-dependent manner, promotes lipid metabolism in adipose tissue, and may have protective effects on pancreatic beta cells. Dual GIP/GLP-1 receptor agonists such as tirzepatide have demonstrated superior glycemic control and weight reduction compared to selective GLP-1 receptor agonists alone, suggesting synergistic metabolic benefits from targeting both incretin pathways.

Glycation is the non-enzymatic covalent bonding of a sugar molecule to a protein or lipid, forming advanced glycation end-products (AGEs). AGE accumulation accelerates with age and in diabetes, contributing to tissue stiffness, chronic inflammation, and oxidative stress. Carnosine is a notable anti-glycation dipeptide that scavenges reactive carbonyl species and prevents AGE formation, which is particularly relevant to diabetic complications and skin aging.

Glycosaminoglycans (GAGs) are long unbranched polysaccharides composed of repeating disaccharide units that are major structural components of the extracellular matrix. GAGs including hyaluronic acid, chondroitin sulfate, and dermatan sulfate provide hydration, cushioning, and signaling functions in connective tissue. GHK-Cu has been shown to stimulate glycosaminoglycan synthesis, contributing to its wound healing and tissue remodeling properties.

A growth hormone secretagogue (GHS) is any compound that stimulates the release of growth hormone from the anterior pituitary gland. GHS peptides typically act through the ghrelin receptor (GHS-R1a) or growth hormone-releasing hormone receptor (GHRH-R) to amplify pulsatile GH release. Major categories include GHRP peptides (GHRP-2, GHRP-6, ipamorelin) that act on the ghrelin receptor and GHRH analogs (sermorelin, tesamorelin, CJC-1295) that act on the GHRH receptor.

Growth Hormone-Releasing Hormone (GHRH) is a 44-amino acid peptide hormone produced in the arcuate nucleus of the hypothalamus that stimulates the anterior pituitary gland to synthesize and secrete growth hormone (GH). GHRH acts through the GHRH receptor (GHRHR), a G protein-coupled receptor on somatotroph cells, triggering intracellular cAMP signaling cascades. Synthetic GHRH analogs such as sermorelin, tesamorelin, and CJC-1295 have been developed for research into growth hormone deficiency, body composition, and age-related decline in GH pulsatility.

Growth Hormone-Releasing Peptides (GHRPs) are a class of synthetic peptides that stimulate growth hormone secretion by acting on the ghrelin receptor (GHS-R1a) in the hypothalamus and pituitary gland. Unlike GHRH, which acts through its own distinct receptor, GHRPs mimic the action of endogenous ghrelin and can amplify GH release synergistically when combined with GHRH. Notable GHRPs include GHRP-2, GHRP-6, hexarelin, and ipamorelin, each differing in their selectivity and side-effect profiles regarding cortisol and prolactin co-release.

In pharmacology, half-life is the time required for the concentration of a substance in the body to decrease by 50%. For peptides, half-lives are generally short (minutes to hours) due to rapid enzymatic degradation by proteases. Understanding a peptide's half-life is essential for research protocol design, as it determines dosing frequency and timing of measurements. Modifications such as PEGylation or cyclization can extend peptide half-lives.

Hepatocyte Growth Factor (HGF) is a paracrine growth factor that binds to the c-Met receptor tyrosine kinase to regulate cell growth, motility, morphogenesis, and tissue regeneration across multiple organ systems. Originally identified for its role in liver regeneration, HGF/c-Met signaling has since been shown to be critical for neuronal survival, synaptic plasticity, and cognitive function. The small molecule peptide dihexa was designed as an HGF/c-Met system modulator and has demonstrated potent procognitive effects in animal models by augmenting HGF-mediated neurotrophic signaling.

High-Performance Liquid Chromatography (HPLC) is an analytical technique used to separate, identify, and quantify components in a mixture. In peptide research, HPLC is the gold standard for determining peptide purity by separating the target peptide from synthesis byproducts, truncated sequences, and other impurities. The resulting chromatogram shows peaks corresponding to each component, with the main peak area percentage indicating purity.

The hypothalamic-pituitary axis is the neuroendocrine system connecting the hypothalamus to the anterior pituitary gland, governing the secretion of hormones including growth hormone, gonadotropins, thyroid-stimulating hormone, and ACTH. Hypothalamic releasing hormones (GHRH, GnRH, TRH) travel via the portal circulation to stimulate pituitary hormone release. Many research peptides — including sermorelin, gonadorelin, and PE-22-28 — act on components of these axes.

IC50 is a quantitative pharmacological measure indicating the concentration of an inhibitor required to reduce a specific biological or biochemical function by 50%. It is widely used to characterize the potency of antagonists, enzyme inhibitors, and cytotoxic agents in dose-response studies. A lower IC50 value indicates greater potency, meaning less compound is needed to achieve half-maximal inhibition. IC50 values are context-dependent and can vary with assay conditions, substrate concentrations, and incubation times, so comparisons are most meaningful when determined under identical experimental conditions.

Immunomodulation refers to the therapeutic adjustment of immune system activity, either by enhancing (immunostimulation) or suppressing (immunosuppression) immune responses to achieve a desired clinical or research outcome. Immunomodulatory agents can target innate immunity (macrophages, NK cells, dendritic cells), adaptive immunity (T and B lymphocytes), or regulatory networks (cytokines, checkpoint pathways). Several research peptides exhibit immunomodulatory properties, including thymosin alpha-1, which enhances T-cell maturation and dendritic cell function, and KPV, which suppresses pro-inflammatory NF-kB signaling. Understanding immunomodulation is essential for peptide research in infectious disease, autoimmunity, and cancer immunology.

In vitro (Latin for 'in glass') refers to experiments performed outside of a living organism, typically in cell cultures, tissue samples, or biochemical assays conducted in laboratory glassware or plates. In vitro studies are an essential early phase of peptide research, allowing investigators to characterize receptor binding, cell signaling, cytotoxicity, and mechanism of action before progressing to animal models.

In vivo (Latin for 'within the living') refers to experiments conducted within a whole living organism, such as animal models or clinical human trials. In vivo studies assess systemic pharmacokinetics, tissue distribution, efficacy, toxicity, and behavioral outcomes that cannot be captured in cell-based assays. Most peptide research progresses from in vitro characterization to in vivo preclinical studies before any potential clinical translation.

Incretins are gut-derived hormones released in response to nutrient intake that potentiate glucose-dependent insulin secretion from pancreatic beta cells, a phenomenon known as the incretin effect. The two primary incretins are glucagon-like peptide-1 (GLP-1), secreted by intestinal L-cells, and glucose-dependent insulinotropic polypeptide (GIP), secreted by K-cells. Together, they account for approximately 50-70% of postprandial insulin release. The development of incretin-based therapies, including GLP-1 receptor agonists (semaglutide), dual GIP/GLP-1 agonists (tirzepatide), and triple agonists (retatrutide), represents one of the most significant advances in metabolic disease research.

Insulin resistance is a condition in which cells in muscle, fat, and liver respond poorly to insulin signaling, impairing glucose uptake and leading to compensatory hyperinsulinemia. It is a central feature of type 2 diabetes and metabolic syndrome. Several research peptides address metabolic pathways related to insulin resistance — GLP-1 receptor agonists (semaglutide, tirzepatide) improve insulin sensitivity, and MOTS-c activates AMPK to enhance glucose metabolism.

Insulin-like Growth Factor 1 (IGF-1) is a 70-amino acid polypeptide hormone with structural homology to insulin that mediates many of the growth-promoting effects of growth hormone. Primarily produced in the liver in response to GH stimulation, IGF-1 circulates bound to IGF-binding proteins (IGFBPs) and acts through the IGF-1 receptor to stimulate cell proliferation, differentiation, and inhibition of apoptosis in virtually all tissues. IGF-1 is central to the GH/IGF-1 axis, and its signaling is a key regulator of musculoskeletal growth, metabolic function, and tissue repair.

Intranasal delivery is a non-invasive route of administration in which a substance is applied to the nasal mucosa, allowing absorption through the highly vascularized nasal epithelium into systemic circulation. This route bypasses first-pass hepatic metabolism and, importantly for neuropeptides, may provide a direct nose-to-brain pathway via the olfactory and trigeminal nerve pathways that circumvents the blood-brain barrier. Several research peptides including semax, selank, and oxytocin have been formulated for intranasal delivery to target central nervous system effects more directly.

Lipidation is the covalent attachment of a fatty acid chain to a peptide, typically to promote non-covalent binding to serum albumin and thereby extend the circulating half-life. This approach is central to the design of long-acting GLP-1 receptor agonists — semaglutide features a C18 fatty diacid linker that enables once-weekly dosing by dramatically slowing renal clearance and proteolytic degradation.

Lipolysis is the metabolic process by which stored triglycerides in adipocytes are hydrolyzed into free fatty acids and glycerol for use as energy substrates. The process is regulated by hormones (catecholamines, insulin, growth hormone, natriuretic peptides) and intracellular enzymes including adipose triglyceride lipase (ATGL), hormone-sensitive lipase (HSL), and monoacylglycerol lipase (MGL). Activation of the cAMP/PKA signaling pathway by beta-adrenergic stimulation or growth hormone is a primary driver of lipolysis. The peptide fragment AOD-9604, derived from the C-terminal region of human growth hormone, has been investigated for its lipolytic activity without the diabetogenic effects associated with full-length GH.

Lyophilization, commonly known as freeze-drying, is a dehydration process used to preserve peptides and other biologics. The process involves freezing the peptide solution, then reducing the surrounding pressure to allow the frozen water to sublimate directly from solid to gas. This produces a stable, lyophilized powder that maintains peptide integrity and can be stored long-term at low temperatures. Reconstitution with bacteriostatic water restores the peptide to its active solution form.

Lyophilized powder is the final product form of a peptide that has undergone lyophilization (freeze-drying). It appears as a white to off-white fluffy or cake-like powder in the bottom of a sealed vial. This form offers maximum stability for storage and shipping, as the removal of water prevents hydrolysis and other degradation reactions. Most research peptides are supplied as lyophilized powder and require reconstitution with bacteriostatic water or another appropriate solvent before use. Properly stored lyophilized peptides can remain stable for months to years at -20°C.

Mass spectrometry (MS) is an analytical technique that measures the mass-to-charge ratio of ions to identify and characterize molecules. In peptide research, MS serves as the definitive identity test — confirming that a peptide has the correct molecular weight and amino acid composition. Common MS techniques for peptides include ESI-MS (Electrospray Ionization), MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization Time-of-Flight), and LC-MS (Liquid Chromatography coupled with Mass Spectrometry). When paired with HPLC, MS provides both purity and identity confirmation.

Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that degrade extracellular matrix components including collagen, elastin, and proteoglycans. MMPs play essential roles in tissue remodeling, wound healing, and angiogenesis, but dysregulated MMP activity contributes to chronic inflammation, tumor invasion, and tissue destruction. GHK-Cu modulates MMP activity by stimulating both MMPs and their tissue inhibitors (TIMPs) to balance matrix turnover.

The melanocortin system is a neuroendocrine signaling network comprising melanocortin peptides (alpha-MSH, beta-MSH, gamma-MSH, and ACTH) derived from proopiomelanocortin (POMC) and their five G protein-coupled receptors (MC1R through MC5R). This system regulates diverse physiological processes including skin pigmentation (MC1R), adrenal steroidogenesis (MC2R), energy homeostasis and appetite (MC3R/MC4R), and exocrine gland function (MC5R). Synthetic melanocortin analogs such as melanotan II and bremelanotide (PT-141) target specific melanocortin receptor subtypes and have been studied for their effects on pigmentation and sexual function.

Mitochondria are double-membrane organelles that serve as the primary site of aerobic energy production through oxidative phosphorylation, generating ATP via the electron transport chain. Beyond energy metabolism, mitochondria regulate calcium homeostasis, apoptosis, reactive oxygen species production, and biosynthetic pathways. Mitochondrial dysfunction, characterized by reduced ATP output, increased ROS generation, and impaired mitochondrial dynamics (fission/fusion), is a hallmark of aging and is implicated in neurodegenerative diseases, metabolic disorders, and cardiomyopathies. The mitochondria-derived peptide MOTS-c and compounds such as methylene blue have been studied for their roles in supporting mitochondrial function and bioenergetics.

Mitochondrial-derived peptides (MDPs) are a class of bioactive peptides encoded within the mitochondrial genome rather than nuclear DNA. The three established MDPs are humanin, MOTS-c, and the SHLP family (small humanin-like peptides). MDPs function as retrograde signaling molecules from mitochondria to the nucleus and other tissues, playing roles in metabolic regulation, stress response, and cytoprotection. Their discovery revealed mitochondria as active endocrine organelles.

Molecular weight (MW), also called molecular mass, is the sum of the atomic weights of all atoms in a molecule, expressed in Daltons (Da) or grams per mole (g/mol). For peptides, molecular weight is determined by the amino acid sequence and any post-translational modifications. It is a key identifier used in quality control — mass spectrometry confirms that a synthesized peptide matches its expected molecular weight. Peptides are generally defined as chains under 50 amino acids (roughly under 5,500 Da).

Myostatin (also known as growth differentiation factor 8, GDF-8) is a member of the TGF-beta superfamily that acts as a negative regulator of skeletal muscle mass. Myostatin signals through activin type II receptors to inhibit myoblast proliferation and satellite cell activation. Follistatin is a natural myostatin antagonist that binds and neutralizes myostatin, and research into myostatin inhibition has significant implications for muscle wasting conditions and age-related sarcopenia.

A neuropeptide is a peptide that functions as a neurotransmitter or neuromodulator within the nervous system, typically released from dense-core vesicles at synapses. Neuropeptides modulate pain perception, mood, appetite, social behavior, and neuroendocrine function. Research-relevant neuropeptides include oxytocin (social bonding), VIP (vasoactive intestinal peptide), DSIP (sleep regulation), and the melanocortin peptides (PT-141, melanotan II) that act through CNS receptor systems.

Neuroprotection refers to mechanisms and strategies that preserve neuronal structure and function against injury, degeneration, or disease. Neuroprotective agents may act by reducing excitotoxicity, scavenging free radicals, inhibiting apoptosis, or promoting neurotrophic factor expression. Peptides such as Semax, Selank, Cerebrolysin, Dihexa, and PE-22-28 have demonstrated neuroprotective properties through various mechanisms in preclinical research.

Neurotrophic factors are a family of secreted proteins that promote the survival, development, and function of neurons. Key neurotrophic factors include brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and hepatocyte growth factor (HGF). Several research peptides modulate neurotrophic factor expression — Semax upregulates BDNF and NGF, Cerebrolysin contains neurotrophic peptide fragments, and Dihexa activates the HGF/c-Met system.

NF-kB is a family of inducible transcription factors (RelA/p65, RelB, c-Rel, p50, p52) that regulate the expression of genes involved in inflammation, immune responses, cell survival, and proliferation. In its inactive state, NF-kB is sequestered in the cytoplasm by inhibitory IkB proteins; upon stimulation by cytokines, pathogens, or stress signals, the IKK complex phosphorylates IkB, leading to its degradation and nuclear translocation of NF-kB. Chronic NF-kB activation is implicated in inflammatory diseases and aging (inflammaging), and the tripeptide KPV (Lys-Pro-Val) derived from alpha-MSH has demonstrated NF-kB inhibitory properties in preclinical models.

Nicotinamide Adenine Dinucleotide (NAD+) is an essential coenzyme present in all living cells that serves as a critical electron carrier in mitochondrial oxidative phosphorylation and a substrate for enzymes including sirtuins, PARPs, and CD38. NAD+ levels decline with age, contributing to mitochondrial dysfunction, impaired DNA repair, and metabolic dysregulation. Strategies to boost NAD+ levels, including supplementation with precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), as well as peptide-based interventions, are active areas of longevity research.

A nootropic is a substance that enhances cognitive function, including memory, attention, learning, or executive function. Peptide nootropics work through diverse mechanisms: Semax increases BDNF and NGF expression, Selank modulates enkephalin metabolism and GABAergic signaling, Dihexa promotes synaptogenesis via the HGF/c-Met system, and PE-22-28 acts through novel TRH receptor subtypes in the hippocampus.

Oxidative stress is a condition arising from an imbalance between the production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) and the capacity of cellular antioxidant defense systems to neutralize them. Excessive ROS damage DNA, proteins, and lipid membranes, contributing to cellular dysfunction, inflammation, and the pathogenesis of numerous diseases including neurodegeneration, cardiovascular disease, and accelerated aging. Endogenous antioxidant defenses include glutathione, superoxide dismutase, and catalase. Several research peptides including glutathione, MOTS-c, and SS-31 have been studied for their roles in mitigating oxidative damage.

PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides, proteins, or other biomolecules to improve their pharmacological properties. PEGylation increases the hydrodynamic radius of the molecule, reducing renal clearance, shielding it from proteolytic degradation, and decreasing immunogenicity, thereby significantly extending the circulating half-life. This technology has been widely applied in peptide drug development, with PEGylated analogs often achieving dosing intervals of once weekly or less compared to daily injections for unmodified peptides.

A peptide bond is a covalent chemical bond formed between the carboxyl group of one amino acid and the amino group of another, with the loss of a water molecule (condensation reaction). This amide bond is the fundamental linkage that connects amino acids in a peptide chain. Peptide bonds are planar and relatively rigid, which influences the overall three-dimensional folding of the peptide. The number of peptide bonds in a chain is one fewer than the number of amino acids.

Peptide cyclization is a chemical modification in which the linear peptide chain is constrained into a ring structure through covalent bond formation between the N-terminus and C-terminus (head-to-tail), between side chains (side chain-to-side chain via disulfide or lactam bridges), or between a terminus and a side chain. Cyclic peptides generally exhibit enhanced metabolic stability, improved receptor selectivity, and increased resistance to proteolytic degradation compared to their linear counterparts. Notable cyclic peptides in research include melanotan II and bremelanotide (PT-141), which are cyclic lactam analogs of alpha-MSH with enhanced melanocortin receptor binding.

Peptide purity refers to the percentage of the target peptide present in a sample relative to all peptide-related species, as determined by HPLC analysis. Research-grade peptides are typically >95% pure, while pharmaceutical-grade exceeds 99%. Impurities can include deletion sequences (missing one or more amino acids), truncated sequences, oxidized forms, and racemized products. Higher purity is critical for research reproducibility, as impurities can introduce confounding variables. Purity should not be confused with peptide content, which measures the peptide fraction versus non-peptide components like water, salts, and counter-ions.

Pharmacodynamics is the study of the biochemical and physiological effects of a substance on the body and its mechanisms of action at the molecular, cellular, and organ system levels. While pharmacokinetics describes what the body does to a compound, pharmacodynamics describes what the compound does to the body. Key pharmacodynamic parameters include potency (EC50/IC50), efficacy (maximal effect), receptor binding affinity, and selectivity profile. In peptide research, understanding pharmacodynamics is essential for characterizing receptor interactions, defining dose-response relationships, and predicting functional outcomes in biological systems.

Pharmacokinetics is the branch of pharmacology concerned with how the body processes a substance over time, commonly described by the acronym ADME: Absorption (how and how fast the compound enters the bloodstream), Distribution (how it spreads through tissues), Metabolism (how it is biochemically modified), and Elimination (how it is removed from the body). For peptides, pharmacokinetic considerations are especially important because native peptides typically have very short half-lives due to rapid proteolytic degradation and renal clearance. Structural modifications such as PEGylation, fatty acid acylation, cyclization, and D-amino acid substitution are employed to improve the pharmacokinetic profiles of research peptides.

A preclinical study is any laboratory research conducted before human clinical trials, encompassing in vitro experiments and in vivo animal model studies. Preclinical studies evaluate a compound's pharmacology, toxicology, pharmacokinetics, and mechanism of action to determine whether it has sufficient safety and efficacy data to justify advancement to human testing. The majority of peptide research literature consists of preclinical data.

Proteolysis is the hydrolytic cleavage of peptide bonds within proteins and peptides, catalyzed by enzymes called proteases. This process is a major challenge in peptide therapeutics because endogenous proteases rapidly degrade administered peptides, limiting their bioavailability and duration of action. Strategies to resist proteolysis include D-amino acid substitution, cyclization, PEGylation, and non-natural amino acid incorporation.

A receptor agonist is a molecule that binds to a biological receptor and activates it, mimicking the effect of the endogenous ligand to produce a biological response. Agonists can be classified as full agonists (producing maximal receptor activation), partial agonists (producing submaximal activation even at saturating concentrations), or superagonists (producing a greater response than the natural ligand). Many research peptides function as receptor agonists, such as GLP-1 receptor agonists like semaglutide, melanocortin receptor agonists like PT-141, and growth hormone secretagogue receptor agonists like ipamorelin.

A receptor antagonist is a molecule that binds to a receptor without activating it, thereby blocking or dampening the biological response normally triggered by endogenous ligands or agonists. Competitive antagonists bind to the same orthosteric site as the agonist and can be overcome by increasing agonist concentration, while non-competitive antagonists bind to allosteric sites and reduce the maximal response regardless of agonist concentration. Understanding antagonism is important in peptide research for characterizing receptor selectivity, designing control experiments, and developing therapeutic peptides that modulate overactive signaling pathways.

Receptor selectivity describes the preference of a ligand for binding to one receptor type or subtype over others. High selectivity means a compound activates its intended target with minimal off-target effects, improving the safety profile. Ipamorelin is notable for its high selectivity for the GHS-R1a receptor without significantly affecting ACTH, cortisol, or prolactin levels, unlike less selective growth hormone secretagogues.

Reconstitution is the process of dissolving a lyophilized (freeze-dried) peptide powder back into solution using an appropriate solvent, typically bacteriostatic water or sterile water. Proper reconstitution technique is critical for research accuracy: the solvent should be added slowly along the vial wall, allowing the powder to dissolve without agitation, as vigorous shaking can damage peptide structures. The resulting solution concentration depends on the volume of solvent added.

Satellite cells are quiescent muscle stem cells located between the sarcolemma and basal lamina of skeletal muscle fibers. Upon activation by injury or growth signals, satellite cells proliferate, differentiate into myoblasts, and fuse with existing muscle fibers to enable repair and hypertrophy. Follistatin promotes satellite cell activation by antagonizing myostatin, and TB-500 (thymosin beta-4) supports muscle repair partly through effects on progenitor cell migration.

A senolytic is any agent that selectively induces apoptosis in senescent cells while sparing healthy, non-senescent cells. By clearing accumulated senescent cells, senolytics aim to reduce the burden of the senescence-associated secretory phenotype (SASP) and restore tissue function. The peptide FOXO4-DRI is a notable senolytic that works by disrupting the FOXO4-p53 interaction that maintains senescent cell survival.

Sequence analysis in peptide science refers to the determination and verification of the amino acid sequence (primary structure) of a peptide. Methods include Edman degradation, which sequentially removes and identifies N-terminal residues, and tandem mass spectrometry (MS/MS), which fragments peptides and deduces sequences from fragmentation patterns. Sequence confirmation is a critical quality control step in peptide manufacturing, ensuring that the synthesized product matches the intended target sequence and that no deletion, insertion, or substitution errors occurred during solid-phase peptide synthesis.

Signal transduction is the process by which an extracellular signal (such as a peptide binding to its receptor) is converted into a cellular response through a cascade of intracellular molecular events. Common signaling pathways in peptide research include the cAMP/PKA pathway (activated by GLP-1 and GHRH agonists), the MAPK/ERK pathway (involved in growth factor signaling), and the JAK/STAT pathway (relevant to immunomodulatory peptides).

Sirtuins are a family of seven NAD+-dependent deacylase enzymes (SIRT1-SIRT7) that regulate critical cellular processes including DNA repair, mitochondrial biogenesis, inflammation, and metabolic homeostasis. SIRT1 and SIRT3 are particularly implicated in longevity pathways, as they mediate the beneficial effects of caloric restriction by deacetylating histones, transcription factors, and metabolic enzymes. Sirtuin activity is directly dependent on NAD+ availability, linking age-related NAD+ decline to reduced sirtuin function and the hallmarks of aging.

The SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment protein REceptor) complex is a protein machinery essential for membrane fusion events including neurotransmitter release at synaptic junctions. The core complex consists of vesicle-associated v-SNAREs (synaptobrevin/VAMP) and target membrane t-SNAREs (syntaxin and SNAP-25) that assemble into a four-helix bundle to drive vesicle-membrane fusion. In dermatological research, peptides such as SNAP-8 (acetyl octapeptide-3) have been designed to competitively inhibit SNARE complex formation, thereby reducing neurotransmitter release at neuromuscular junctions and attenuating expression lines.

Solid-Phase Peptide Synthesis (SPPS) is the standard method for chemical synthesis of peptides, developed by Robert Bruce Merrifield in 1963 (Nobel Prize, 1984). In SPPS, the C-terminal amino acid is anchored to an insoluble polymer resin, and the peptide chain is assembled stepwise from C-terminus to N-terminus through repeated cycles of deprotection and amino acid coupling. The two main strategies are Boc (tert-butyloxycarbonyl) and Fmoc (fluorenylmethyloxycarbonyl) chemistry, with Fmoc-SPPS being predominant in modern peptide production due to milder cleavage conditions. SPPS enables the synthesis of research-grade peptides with precise sequence control.

Subcutaneous (SC or SubQ) injection is a route of administration in which a substance is delivered into the subcutaneous tissue layer (hypodermis) between the skin and underlying muscle. This route provides slower, more sustained absorption compared to intravenous or intramuscular injection, resulting in a depot effect that can extend the duration of action. Subcutaneous injection is the most common administration route for research peptides due to its ease of use, reliable absorption, avoidance of first-pass metabolism, and suitability for self-administration in clinical study settings.

A synthetic peptide is a peptide manufactured through chemical synthesis rather than biological extraction, most commonly using solid-phase peptide synthesis (SPPS). Synthetic production allows precise control over sequence, purity, and incorporation of non-natural amino acids or modifications. The vast majority of research peptides available commercially are produced synthetically, enabling consistent quality and scalability.

Telomerase is a ribonucleoprotein reverse transcriptase enzyme composed of a catalytic subunit (TERT) and an RNA template component (TERC) that maintains telomere length by adding repetitive TTAGGG nucleotide sequences to chromosome ends. In most somatic cells, telomerase activity is repressed, leading to progressive telomere shortening with each cell division and eventual replicative senescence. Telomerase reactivation has been a focus of aging research, with the tetrapeptide epithalon (Ala-Glu-Asp-Gly) shown in preclinical studies to activate telomerase gene expression in human somatic cells.

Telomeres are repetitive nucleotide sequences (TTAGGG in vertebrates) capped by a protein complex called shelterin that protect the ends of chromosomes from degradation, end-to-end fusion, and recognition as DNA damage. Telomeres shorten with each cell division due to the end-replication problem, and critically short telomeres trigger cellular senescence or apoptosis. Telomere length is considered a biomarker of biological aging, and interventions that preserve or extend telomeres, including the peptide epithalon, are actively studied in gerontological research.

The therapeutic index (TI) is the ratio between the toxic dose and the therapeutic dose of a compound, expressed as TD50/ED50. A wide therapeutic index indicates a large margin of safety between the effective and toxic concentrations. Many peptides exhibit favorable therapeutic indices compared to small molecule drugs due to their high receptor specificity and predictable metabolism.

The thymus is a specialized primary lymphoid organ located in the anterior mediastinum, responsible for the maturation, differentiation, and selection of T lymphocytes (T cells) essential for adaptive immunity. The thymus is most active during childhood and undergoes progressive involution (shrinkage and replacement with adipose tissue) with age, a process that contributes to immunosenescence and reduced immune competence in older individuals. Thymic peptides including thymosin alpha-1 and thymalin have been isolated from thymic extracts and studied for their immunomodulatory properties, particularly their ability to restore T-cell function and enhance immune surveillance.

Transdermal delivery is the administration of a compound through the skin for systemic or local distribution. For peptides, the stratum corneum barrier typically limits passive transdermal absorption, requiring penetration enhancement strategies such as microneedles, iontophoresis, chemical enhancers, or liposomal formulations. Cosmetic peptides like Matrixyl and SNAP-8 (Argireline) are formulated for topical application, while research-grade peptides more commonly use subcutaneous or intranasal routes.

Vascular Endothelial Growth Factor (VEGF) is a family of signaling glycoproteins (VEGF-A, VEGF-B, VEGF-C, VEGF-D, PlGF) that are key regulators of angiogenesis, vasculogenesis, and vascular permeability. VEGF-A, the most studied isoform, binds to VEGFR-1 and VEGFR-2 tyrosine kinase receptors on endothelial cells, triggering signaling cascades that promote endothelial cell proliferation, migration, and tube formation. BPC-157 has been shown to upregulate VEGF expression in multiple tissue injury models, contributing to its observed wound-healing and tissue-protective properties.